Pliant Therapeutics, Inc. SEC filings PLRX
Pliant Therapeutics, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jul 20, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2026 | Apr 14, 2026 |
| EFFECT | Filing | Apr 6, 2026 | — |
| CORRESP | Letter to the SEC | Apr 2, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2026 | — |
| S-3 | Shelf registration | Mar 30, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 30, 2026 | Mar 27, 2026 |
| S-8 | Employee stock plan registration | Mar 11, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 11, 2026 | Mar 11, 2026 |
| 10-K | Annual report | Mar 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2025 | Dec 2, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 24, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Agreement ended
|
Oct 20, 2025 | Oct 14, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | Current report | Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2025 | Jun 5, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
May 1, 2025 | May 1, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 5, 2025 |
| PRER14A | Filing | Apr 11, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 13, 2025 | Mar 12, 2025 |
| 8-A12B | Filing | Mar 13, 2025 | — |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Other events
|
Feb 13, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Other events
|
Feb 10, 2025 | Feb 7, 2025 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 27, 2024 | Sep 24, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Other events
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Other events
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 6, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| DEF 14A | Proxy statement | Apr 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Mar 12, 2024 | Mar 11, 2024 |
| S-8 | Employee stock plan registration | Feb 27, 2024 | — |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Other events
|
Feb 5, 2024 | Feb 4, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Oct 3, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Other events
|
Sep 26, 2023 | Sep 26, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 7, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Other events
|
May 1, 2023 | Apr 30, 2023 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 26, 2023 | — |
| S-3ASR | Automatic shelf registration | Mar 27, 2023 | — |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Agreement ended
|
Feb 23, 2023 | Feb 17, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 25, 2023 | Jan 23, 2023 |
| 424B5 | Prospectus supplement | Jan 25, 2023 | — |
| S-3MEF | Filing | Jan 24, 2023 | — |
| 424B5 | Prospectus supplement | Jan 23, 2023 | — |
| 8-K |
Current report
Other events
|
Jan 23, 2023 | Jan 23, 2023 |
| 8-K |
Current report
Other events
|
Jan 23, 2023 | Jan 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 18, 2022 | Nov 16, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Sep 16, 2022 | Sep 14, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 14, 2022 | Jul 11, 2022 |
| 424B5 | Prospectus supplement | Jul 14, 2022 | — |
| 424B5 | Prospectus supplement | Jul 11, 2022 | — |
| POS EX | Filing | Jul 11, 2022 | — |
| 8-K |
Current report
Other events
|
Jul 11, 2022 | Jul 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 16, 2022 |
| UPLOAD | Letter from the SEC | Jun 2, 2022 | — |
| EFFECT | Filing | May 31, 2022 | — |
| CORRESP | Letter to the SEC | May 27, 2022 | — |
| 10-K/A | Amended annual report | May 27, 2022 | Dec 31, 2021 |
| UPLOAD | Letter from the SEC | May 17, 2022 | — |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
May 5, 2022 | May 4, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 16, 2022 |
| 10-K/A | Amended annual report | Mar 1, 2022 | Dec 31, 2021 |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| POS AM | Filing | Mar 1, 2022 | — |
| 8-K/A |
Amended current report
Results of operations
|
Mar 1, 2022 | Feb 28, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| POSASR | Filing | Feb 28, 2022 | — |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Other events
|
Sep 7, 2021 | Sep 7, 2021 |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| S-3ASR | Automatic shelf registration | Jul 2, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2021 | Jun 29, 2021 |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 29, 2021 |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| 10-K | Annual report | Mar 16, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2021 | Mar 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 13, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 21, 2020 | Dec 15, 2020 |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 10-Q | Quarterly report | Aug 11, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2020 | Aug 11, 2020 |
| S-8 | Employee stock plan registration | Jun 4, 2020 | — |
| 424B4 | Prospectus | Jun 3, 2020 | — |
| EFFECT | Filing | Jun 2, 2020 | — |
| S-1/A | Amended registration statement | Jun 2, 2020 | — |
| CERT | Filing | Jun 1, 2020 | — |
| 8-A12B | Filing | May 29, 2020 | — |
| CORRESP | Letter to the SEC | May 29, 2020 | — |
| CORRESP | Letter to the SEC | May 29, 2020 | — |
| CORRESP | Letter to the SEC | May 26, 2020 | — |
| S-1/A | Amended registration statement | May 26, 2020 | — |
| UPLOAD | Letter from the SEC | May 20, 2020 | — |
| CORRESP | Letter to the SEC | May 13, 2020 | — |
| S-1 | Registration statement | May 11, 2020 | — |
| CORRESP | Letter to the SEC | May 8, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2020 | — |
| DRS/A | Filing | Apr 10, 2020 | — |
| DRSLTR | Filing | Apr 9, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 26, 2020 | — |
| DRS/A | Filing | Mar 16, 2020 | — |
| D/A | Filing | Mar 11, 2020 | — |
| D | Filing | Jan 9, 2020 | — |
| DRSLTR | Filing | Jul 17, 2019 | — |
| DRS/A | Filing | Jul 17, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2019 | — |
| DRSLTR | Filing | Jun 20, 2019 | — |
| DRS/A | Filing | Jun 20, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2019 | — |
| DRS | Filing | May 10, 2019 | — |
| D/A | Filing | Jul 20, 2018 | — |
| D | Filing | Jul 20, 2018 | — |
Showing 164 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PLRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1746473
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.